Moderna shares are trading lower after the company announced it received a refusal-to-file letter from the FDA for mRNA-1010.
Moderna +2.69% Pre
Moderna MRNA | 54.26 54.20 | +2.69% -0.12% Pre |
Moderna shares are trading lower after the company announced it received a refusal-to-file letter from the FDA for mRNA-1010.
